By week 4, the scale had moved again
It is important to note that claims about increased energy expenditure in humans remain insufficiently evidenced at this stage, and the net glycaemic effects reflect observed trial outcomes rather than a straightforward mechanistic reduction in hepatic glucose output the concurrent glucagon receptor agonism may, in fact, influence hepatic glucose production in a complex and not fully characterised manner
In a clinical trial setting, your trial team will also have specific adverse event reporting procedures
Importantly, these factors dont just influence GLP-1they are also influenced by GLP-1, especially its effects on metabolic function and appetite regulation
Diabetes Care 40 , 6976 (2017)
A small subset of participants, approximately 12%, continued losing through week 48 without plateauing